Gastrin Hormone Market Players:
- Merck KGaA
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- RayBiotech Life, Inc.
- KareBay Biochem, Inc.
- Cayman Chemical Company
- Cambridge Bioscience Limited
- CPC Scientific Inc.
- Abcepta
- GenScript Biotech Corporation
- Qingdao Echemi Technology Co., Ltd.
- VWR International, LLC
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of gastrin hormone is assessed at USD 988.7 million.
The global gastrin hormone market size was valued at over USD 943.69 million in 2025 and is expected to expand at a CAGR of around 5.3%, surpassing USD 1.58 billion revenue by 2035.
North America is poised to capture a 35% share by 2035 in the gastrin hormone market, owing to favorable reimbursement policies and rising healthcare expenditure.
Key players in the market include Merck KGaA, RayBiotech Life, Inc., KareBay Biochem, Inc., Cayman Chemical Company, Cambridge Bioscience Limited, CPC Scientific Inc., Abcepta, GenScript Biotech Corporation, Qingdao Echemi Technology Co., Ltd., VWR International, LLC.
